Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Non-active site mutations such as L50F are crucial ...

Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

"Our findings suggest that individuals with reduced PTPN2 activity may face a higher risk of infection due to the upregulation of ACE2, which serves as the entry point for SARS-CoV-2 into human ...

They identified mutation hotspots, notably in the spike protein RNA, crucial for viral entry and ... the underlying mechanism that has enabled them to calculate SARS-CoV-2's mutation rate.

The novel live-attenuated SARS-CoV-2 nasal vaccine candidate is highly safe, induces robust cellular and mucosal immunity, and generates long-lasting neutralizing antibody titers.

Understanding the genetic mechanism fueling SARS-CoV-2's ability to generate variants can go a long way in keeping COVID at ...

Athena Akrami has not been well since March 2020, when she first experienced symptoms of a SARS-CoV-2 infection. Although the initial infection cleared within weeks, more than a year later Akrami ...

The SARS-CoV-2 spike (S) protein mediates its ... PTPN2 deficiency increases ACE2 expression and viral entry through a STAT1-dependent mechanism. STAT1/3 are PTPN2 substrates that are directly ...